Pancreatic Cancer Research

ResearcherUniversity of Electronic Science and Technology of ChinaNo recent work listed

Yutong Yao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-5672-4593; OpenAlex author ID A5103275046. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 2 papers

Papers 2

  1. The expression of m6A regulators correlated with the immune microenvironment plays an important role in the prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/gs-21-859↗
  2. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fgene.2022.848391↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xubao Liu · 1 shared paper, 2022 · strength 0.16
  2. Junjie Xiong · 1 shared paper, 2022 · strength 0.16
  3. Nengwen Ke · 1 shared paper, 2022 · strength 0.16
  4. Chunlu Tan · 1 shared paper, 2022 · strength 0.16
  5. Yonghua Chen · 1 shared paper, 2022 · strength 0.16
  6. Yuxin Liang · 1 shared paper, 2022 · strength 0.15
  7. Jin Shang · 1 shared paper, 2022 · strength 0.15
  8. Zilong Zhang · 1 shared paper, 2022 · strength 0.15
  9. Xiaolun Huang · 1 shared paper, 2022 · strength 0.15
  10. Deyuan Zhong · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.